Yarrowia lipolytica Polypeptide Secretion via Acid Protease Signal

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current expression systems, particularly Saccharomyces cerevisiae, face limitations such as low heterologous protein production and hyperglycosylation, necessitating the exploration of alternative yeast species like Yarrowia lipolytica for mammalian-like post-translational modifications and efficient polypeptide production in biotechnological applications.

Innovation Solution

A genetic construct for Yarrowia lipolytica incorporating an acid extracellular protease secretion signal sequence and flanking zeta sequence recombination sites is developed, enabling the expression and secretion of polypeptides into the extracellular space or onto the cell wall, utilizing a plasmid-based expression vector with specific restriction enzyme sites for integration and transformation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If Saccharomyces cerevisiae is used as the expression system, then the system is well-established and easy to operate, but heterologous protein production is low and hyperglycosylation occurs

Engineering Contradiction:
Improveease of operationVSAvoidheterologous protein production
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The patent extracts the expression system from the conventional S. cerevisiae to Y. lipolytica, which naturally produces lower levels of hyperglycosylation and allows for improved heterologous protein production while maintaining ease of operation through well-established yeast transformation protocols

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the biological parameters of the expression system by switching from S. cerevisiae to Y. lipolytica, which has different glycosylation patterns and protein secretion capabilities, thereby improving both productivity and product quality

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If Saccharomyces cerevisiae is used as the expression system, then the system is well-established and easy to operate, but hyperglycosylation of recombinant proteins occurs

Engineering Contradiction:
Improveease of operationVSAvoidpost-translational modification accuracy
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The patent extracts the expression system from S. cerevisiae to Y. lipolytica, which has a more mammalian-like glycosylation profile and produces less hyperglycosylation, thereby improving the accuracy of post-translational modifications while maintaining ease of operation

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the biological parameters of the expression system by switching to Y. lipolytica, which naturally performs more accurate mammalian-like post-translational modifications, reducing hyperglycosylation artifacts

Inventive Principle:
Principle #35Parameter changes

3Productivity

If Yarrowia lipolytica is used as the expression system, then mammalian-like post-translational modifications are achieved and protein production is improved, but the system requires development of specific genetic constructs

Engineering Contradiction:
Improvepolypeptide productionVSAvoidgenetic construct complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent performs preliminary actions by developing and optimizing the genetic construct components (promoters, secretion signals, integration sites) for Y. lipolytica before full-scale protein production, thereby simplifying subsequent expression operations

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses specific genetic elements as intermediaries, such as the acid extracellular protease secretion signal sequence and zeta sequence recombination sites, which mediate between the introduced polypeptide gene and the Y. lipolytica expression machinery

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS9963487B2Production of polypeptides relevant to human and animal health using <i>Yarrowia lipolytica</i>
Publication Date: 2018.05.08 UNIVERSITY OF THE FREE STATE
  • US9963487B2 patent drawing
  • US9963487B2 patent drawing
  • US9963487B2 patent drawing

AI summary

The present invention relates to the expression of polypeptides using Yarrowia lipolytica, in particular the secretion of expressed polypeptides into either the extracellular space or the surface of the Y. lipolytica host cell wall. The invention also extends to the use of the polypeptides so expressed in biotechnological applications. The present invention provides an expression construct for the expression of polypeptides using at least a single Yarrowia lipolytica yeast cell, the expression construct having at least one expression cassette, the expression cassette including an acid extracellular protease secretion signal sequence and flanking zeta sequence recombination sites.